Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology - Test2 - elhamkhani - TriplyDB

Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology

Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology

http://www.wikidata.org/entity/Q27024879

about

Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions-A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of Cardiology Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs Potential new drug treatments for congestive heart failure.Silent disease progression in clinically stable heart failure.The role of elastic restoring forces in right-ventricular filling Trimetazidine attenuates pressure overload-induced early cardiac energy dysfunction via regulation of neuropeptide Y system in a rat model of abdominal aortic constriction.Systolic MOLLI T1 mapping with heart-rate-dependent pulse sequence sampling scheme is feasible in patients with atrial fibrillation Pharmacological Strategies to Retard Cardiovascular Aging Detection of Soluble ED-A(+) Fibronectin and Evaluation as Novel Serum Biomarker for Cardiac Tissue Remodeling.Significance of myocardial tenascin-C expression in left ventricular remodelling and long-term outcome in patients with dilated cardiomyopathy Nitroxyl (HNO) for treatment of acute heart failure.Intercellular communication lessons in heart failure.Cardiac Remodeling: Concepts, Clinical Impact, Pathophysiological Mechanisms and Pharmacologic Treatment.Specific α7 nicotinic acetylcholine receptor agonist ameliorates isoproterenol-induced cardiac remodeling in mice through TGF-β1/Smad3 pathway.Somatic Comorbidity in Schizophrenia: Some Possible Biological Mechanisms Across the Life Span.The myosin activator omecamtiv mecarbil: a promising new inotropic agent.Heart failure-potential new targets for therapy.Global left atrial failure in heart failure.Metabolic support for the heart: complementary therapy for heart failure?Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities.The neuroprotective agent Rasagiline mesylate attenuates cardiac remodeling after experimental myocardial infarction Hormone Therapy to Treat Cardiac Remodeling: Is There Any Evidence?Intramyocardial injection of SERCA2a-expressing lentivirus improves myocardial function in doxorubicin-induced heart failure.Medical and mechanical unloading in advanced heart failure: hope for cardiac recovery?Publishing in a heart failure journal-where lies the scientific interest?Beneficial effects of renal denervation on cardiac angiogenesis in rats with prolonged pressure overload.KLF6 orchestrates cardiac myocyte-to-fibroblast communication: 'He who has ears to hear, let him hear'.Cardiac protein kinases: the cardiomyocyte kinome and differential kinase expression in human failing hearts.Altered myocardial force generation in end-stage human heart failure.Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure Arrhythmogenic Substrates for Atrial Fibrillation in Obesity

P2860

Q26765793-717B7B3E-B9B6-4C14-9F4A-62DAC4B71D99 Q28087776-192518A2-1568-4CE7-905E-B606BE097D8F Q30251531-7967F32C-81AE-4EF6-9185-70C59DD7473B Q33578212-C0D9950F-0FA9-40EA-B3D0-ED9E39C66975 Q36027821-EF64B953-DA72-4CCD-B619-4D36BEDC9AE4 Q36195411-AA625263-D97E-419A-9D8B-4F97D88E0D48 Q36691645-CB5CC3D0-7385-4C94-8889-C250BAFC7334 Q36972415-739FE4C9-57C6-4244-8F32-17AC343BB7AA Q37222913-88DB33CB-EC43-4E1F-BC35-C7F9B32EA0B6 Q37344043-E3BFECF2-F57E-4656-9DE8-96DB8F702B3E Q38224809-1B325DDB-43D8-473F-A7C9-E05BD4D4F94D Q38591546-5AE08B16-406C-4575-B983-DBAC187D52CC Q38662968-660C7255-50AB-462D-9980-4D2A9A4B6CFE Q38667881-DDADBAE2-3027-4FCA-918E-8CE3007B51A7 Q38795094-EDC2F972-A5C7-4CE7-BFE7-0D6EF1478CB4 Q38870685-8561B7B4-2225-4EDD-AD95-B6B7E1152807 Q38882867-E7693CA1-735D-46C9-8E86-4DBA97B3C24D Q38998559-5DAD4FD6-D31E-4F1C-A324-48698648A5A5 Q38998576-2A9C87F9-FF3A-4D89-8F4C-7A7D3E91BDC6 Q39024203-23231414-613A-41DF-815D-D70E8764221F Q39434474-227C0540-033B-4E89-BB7B-BCF5954056B5 Q41239263-ED5BD350-F4B4-4379-9802-48CF31D857F5 Q42374235-B30FB2FD-DBF6-455F-8682-1582E93F7E32 Q45886178-361561DC-D4AC-4A84-90B5-07CDDC495D7C Q47564556-E039C492-7AFE-4D8F-ACA5-3C90AB0E389B Q50048824-FB46FC4A-117B-4160-8200-6531294F0852 Q51542476-DAD32184-0CAB-4D38-BD65-1D1016C4452A Q53712239-16F06F2D-86F2-47FB-B2D7-989CED0F621A Q54253545-B58E265C-D18F-4F0F-A673-E6BDE2CB37EE Q54582387-AAB79E18-DD97-4947-9950-73EBB6EA2AAD Q57816166-A14C5FC0-E9D5-4AB7-B84E-EE2AEADB2C4D Q58580726-28E8825A-0FCD-4D4A-9F42-3D1E5E8743E4

P2860

Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology

http://www.wikidata.org/entity/Q27024879

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Targeting myocardial remodelli ...... European Society of Cardiology

@ast

Targeting myocardial remodelli ...... European Society of Cardiology

@en

Targeting myocardial remodelli ...... European Society of Cardiology

@nl

type

label

Targeting myocardial remodelli ...... European Society of Cardiology

@ast

Targeting myocardial remodelli ...... European Society of Cardiology

@en

Targeting myocardial remodelli ...... European Society of Cardiology

@nl

prefLabel

Targeting myocardial remodelli ...... European Society of Cardiology

@ast

Targeting myocardial remodelli ...... European Society of Cardiology

@en

Targeting myocardial remodelli ...... European Society of Cardiology

@nl

P1433

Q27024879-38AD1747-359B-426F-9C38-39555FB54ECB

P1476

Q27024879-9F4C1792-CCC2-49B2-AAA3-D99086FB4F84

P2093

Q27024879-080BEE57-B088-4717-9030-F09B5885CAD6

Q27024879-68E30C80-FA4A-4BBF-9CB6-EFD074C4622D

Q27024879-86421CDD-487F-4066-990F-FFC49BA3F0EC

Q27024879-87F61845-578A-4B5A-9E75-2C533B801022

Q27024879-8F4A164B-4F24-4B32-B219-581D2D6F3558

Q27024879-DD06CD37-E380-4EA3-ACB2-C5665FB6F25C

P2860

Q27024879-01E1A499-D4CC-48EE-AC1C-8596DF0A9278

Q27024879-07A37BE3-6AD6-4785-B391-41E4E2258B4F

Q27024879-09F9DCA5-15C4-4417-BAF0-7B2EF073A7FE

Q27024879-0C29BA65-4479-423F-B756-7A3FFAA9B7F6

Q27024879-116356F2-7B02-4594-BC89-73E96963B8B4

Q27024879-12E8EF76-0928-4C2D-8EF7-7F6F730C1838

Q27024879-17A9EA6A-F231-40FF-B4A6-9C5CE14C2926

Q27024879-1C11AF27-B2F0-4421-BE32-FEA2AE660521

Q27024879-1DFCE98E-B694-4762-A091-EDA0030E6CF5

Q27024879-25799BF2-8BCB-4BC1-9D6D-AC46885D9AAF

P304

Q27024879-0C356FB5-9510-4F88-88AB-E4BAF6DB284E

P31

Q27024879-55F32937-6A28-494A-92EF-9348808AC4C4

P3181

Q27024879-B1036DB5-47F1-48A0-A929-5ECE366BD282

P356

Q27024879-6D200474-19FC-4157-80AF-D8323B606350

P407

Q27024879-FE80944C-01B7-46D4-B329-A9CE06270148

P433

Q27024879-AB8A4016-78DE-42AF-9268-A267E2DA8421

P478

Q27024879-9E509E72-56C2-4B9B-8424-947F1DBAFF0E

P50

Q27024879-1F113942-FF2F-491B-AD5E-C6C2A2A2F282

Q27024879-51BAE1C4-1614-4975-BDD9-B418CDFD1A88

Q27024879-6025FFC4-5ED0-41CD-A656-3A8A5E1A9395

Q27024879-68BA0FA7-9485-424E-A074-A428D1C7AC07

Q27024879-7A665D6A-908E-4E42-841C-6E327B56F2A5

Q27024879-950266D3-A4D9-4272-ABEA-2A17EE3B4E24

Q27024879-B126EC07-5EE6-4BDF-95CC-2B338AEBBCDC

Q27024879-B6952238-5F58-4F60-8285-E2AC43F014CE

Q27024879-F0B88E5A-6EE5-4790-BD7A-F0FD6347EC91

P577

Q27024879-0167B5D2-2F62-4E53-B13B-D0D49CC40218

P5875

Q27024879-ACC61CFA-5D58-4A4D-9CC4-58EEC6E217CC

P698

Q27024879-8AD0CD8C-3FB8-4CCC-9962-61D6D77621DE

P921

Q27024879-831A36D1-62F7-4779-9945-CF5F6282D190

P3181

P356

P1433

European Journal of Heart Failure

P1476

Targeting myocardial remodelli ...... European Society of Cardiology

@en

P2093

Angela Clerk

http://www.w3.org/2001/XMLSchema#string

Denise Hilfiker-Kleiner

http://www.w3.org/2001/XMLSchema#string

Guido Tarone

http://www.w3.org/2001/XMLSchema#string

Johann Bauersachs

http://www.w3.org/2001/XMLSchema#string

Leon De Windt

http://www.w3.org/2001/XMLSchema#string

Stephane Heymans

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling

Personalized medicine: hope or hype?

The protein kinase complement of the human genome

A thrombospondin-dependent pathway for a protective ER stress response

Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases

MicroRNA-210 as a novel therapy for treatment of ischemic heart disease

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis

Molecular Mechanism of Selectivity among G Protein-Coupled Receptor Kinase 2 Inhibitors

Targeting myocardial substrate metabolism in heart failure: potential for new therapies

MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice

P304

494-508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4010463

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/EJHF.62

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Adelino F Leite-Moreira

André P. Lourenço

Carlo Gabriele Tocchetti

Guido Iaccarino

Jean-Luc Balligand

P577

2014-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260876232

http://www.w3.org/2001/XMLSchema#string

P698

24639064

http://www.w3.org/2001/XMLSchema#string

P921